Homechevron_rightArchiveschevron_rightHealth

Archives

Explore Stories by Date

12 Oct 2026

AI System Achieves 99.6% Accuracy in Rabies Virus Detection, Transforming Global Testing

University of Surrey researchers developed the first AI system for rabies virus detection in cell cultures, achieving 99.6% accuracy. The AI-based workflow analyzes fluorescence images to identify infections and measure vaccine-induced antibody levels, replacing manual microscopy. The breakthrough could accelerate rabies virus detection in endemic countries where the disease kills 59,000 people annually.

2 Sources

09 Oct 2026

Google's AMIE Chatbot Shows Promise in First Real-World Clinical Trial for AI in Healthcare

Google's AMIE chatbot successfully completed an 8-month clinical trial at Beth Israel Deaconess Medical Center, helping doctors prepare for 75% of patient visits. The AI diagnostic chatbot matched final diagnoses 90% of the time and hallucinated only once across 98 patient interactions, marking a significant step for patient-facing conversational AI in urgent care settings.

4 Sources

08 Oct 2026

Brief Safety Reminders Reduce Harmful Clinical AI Decisions by 40% Across 20 Models, Mount Sinai Finds

Mount Sinai researchers discovered that adding brief safety reminders to AI prompts reduced potentially harmful clinical AI decisions from 16.6% to 10.1% across nearly 20 models. The study, analyzing over 10 million AI responses in real-world hospital cases, reveals how prompt framing influences AI behavior in healthcare settings and highlights the urgent need for automated safety testing.

2 Sources

Bryan Johnson Says He Would Never Trust His Health to AI Despite Gathering 4.2 Billion Data Points

Tech entrepreneur Bryan Johnson, known for his extreme longevity regimen, warns against trusting AI for health decisions despite its potential. As one in four Americans use AI chatbots for medical advice, experts highlight risks including AI hallucinations, incomplete patient data, and misinformation that could compromise healthcare outcomes.

2 Sources

AI Transforms mRNA Vaccines Storage and Heart Transplant Monitoring in Medical Breakthroughs

Researchers use AI to eliminate cold storage for mRNA vaccines, enabling room-temperature stability for up to a year and cutting costs by 86%. Separately, AI models trained on ECG readings detect heart transplant rejection with 100% accuracy, eliminating unnecessary biopsies.

2 Sources

07 Oct 2026

Biohub Secures $1.8 Billion for AI Biology Data to Build Universal Virtual Cell

Zuckerberg-backed Biohub announced a $1.8 billion collaboration with Google DeepMind, Meta, the U.S. Department of Energy, and the National Institutes of Health to generate AI-ready biological data. The Virtual Biology Initiative aims to build predictive AI models of biology that could compress drug development timelines from years to months by enabling scientists to digitally simulate biological systems.

12 Sources

06 Oct 2026

AI System MEL-IA Automates Classification of Skin Lesions in Hospital Workflows

The University of Alicante and Sant Joan d'Alacant University Hospital deployed MEL-IA, an AI system that automates classification of skin lesions across five major types. Trained on over 15,000 dermatoscopic images, the system achieved 86% overall accuracy and processed 980 dermatological studies with response times under one second in live hospital settings.

2 Sources

Utah Becomes First State to Allow AI Prescriptions for Acne Treatment Without Direct Doctor Oversight

Utah launched a groundbreaking pilot program allowing AI to examine patients and prescribe acne medication autonomously. Nolla Health's app uses facial scans to generate acne severity scores and issue prescriptions for mild-to-moderate cases at $4.99/month, with gradually reducing physician oversight over three phases.

12 Sources

01 Oct 2026

First Patient Treated in Groundbreaking Armored CAR T-Cell Therapy Trial for Ovarian Cancer

Roswell Park Comprehensive Cancer Center and Generate Biomedicines have dosed the first patient in a clinical trial evaluating GB-5267, an AI-designed IL-18 armored CAR T-cell therapy targeting MUC16 in recurrent ovarian cancer. The treatment aims to overcome immune suppression without requiring chemotherapy-based lymphodepletion.

2 Sources

Get all updates into your inbox 💌, Stay Up-to-date for Free 🥳

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.

Explore

News Categories

Technology Business Policy Startups Health Science Entertainment

Terms Privacy Content Contact Us